Nanomedicine for acute respiratory distress syndrome: The latest application, targeting strategy, and rational design
2021 · Acta Pharmaceutica Sinica B · 173 citations
https://doi.org/10.1016/j.apsb.2021.04.023
Jilin University(CN)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
53
Papers
4.0K
Citations
27
h-index
35
i10-index
Qi Qiao is an academic researcher from Jilin University. The author has contributed to research in topics: Nanoplatforms for cancer theranostics & NF-κB Signaling Pathways & Immunotherapy and Immune Responses. The author has an h-index of 27, co-authored 46 publications.
ORCID: 0000-0003-1809-4984https://doi.org/10.1016/j.apsb.2021.04.023
https://doi.org/10.1158/0008-5472.can-19-3533
Click to start Chat